03 May 2023 Galapagos announces departure of Bart Filius, Chief Operating Officer and Chief Financial Officer Member news
03 May 2023 P95 BV and Ampersand Capital Partners join forces to establish first in class vaccine CRO Member news
02 May 2023 Sequana Medical announces FDA clearance of IND application for DSR® 2.0 for treatment of congestive heart failure Member news
27 Apr 2023 Galapagos initiates Phase 3 program with filgotinib in patients with active axial spondyloarthritis Member news
26 Apr 2023 VIB and Ghent University develop new mRNA vaccines against bacterial infections Member news
25 Apr 2023 Flanders export figures 2022: goods exports up 26%, but growth has slowed since Q4 Member news
24 Apr 2023 Syngenta and Biotalys enter into strategic partnership in biologicals innovation to advance solutions for sustainable agriculture Member news
17 Apr 2023 argenx and Genmab enter partnership to advance antibody therapies in immunology and oncology Member news
15 Apr 2023 argenx announces UK MHRA approval of VYVGART for the treatment of generalized myasthenia gravis Member news
13 Apr 2023 KU Leuven defines biomarkers to predict how cancer patients respond to immunotherapy Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
